Skip to main content
Clinical Trials/NCT04065906
NCT04065906
Unknown
Not Applicable

Near-infrared Spectroscopy Neurofeedback as a Treatment for Children With Attention Deficit Hyperactivity Disorder

Xijing Hospital1 site in 1 country90 target enrollmentJanuary 15, 2019

Overview

Phase
Not Applicable
Intervention
Methylphenidate or Tomoxetine
Conditions
Neurofeedback
Sponsor
Xijing Hospital
Enrollment
90
Locations
1
Primary Endpoint
Change in SNAP-IV
Last Updated
6 years ago

Overview

Brief Summary

To observe the clinical efficacy and mechanism of functional near-infrared spectroscopy imaging neurofeedback therapy for attention deficit and hyperactivity disorder.

Detailed Description

In this study, a parallel controlled study will be conducted to recruit 60 patients with ADHD, 30 patients in the fNIRS group and 30 patients in the drug group. At the same time, 30 healthy controls will be recruited. 6 weeks, 12 sessions of NIRS feedback will be given for participants in NIRS group and healthy controls. 6 weeks of first or second line medication will be given for participants of drug group. Magnetic resonance imaging will be performed at baseline for all participants. SNAP IV, PSQ, CGI will be evaluated at baseline, week 3, week 6 and week 8 for ADHD participants.

Registry
clinicaltrials.gov
Start Date
January 15, 2019
End Date
December 31, 2020
Last Updated
6 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Xijing Hospital
Responsible Party
Principal Investigator
Principal Investigator

Wu Wenjun-1

Department of Psychiatry, Xijing Hospital, The Air Force Medical University

Xijing Hospital

Eligibility Criteria

Inclusion Criteria

  • diagnosed with TD, according to the American Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-5);
  • aged 6-12;
  • right handed;

Exclusion Criteria

  • full-scale intelligence quotient below 80(measured by Wechsler Intelligence Scale for Children,WISC)
  • medical or neurological disorders, psychiatric disorders other than oppositional defiant disorder
  • current participation in a psychotherapeutic treatment

Arms & Interventions

Drug group

Children with ADHD, 6 weeks' treatment of either methylphenidate or tomoxetine

Intervention: Methylphenidate or Tomoxetine

NIRS group

Children with ADHD, 12 sessions of NIRS feedback, for two sessions per week.

Intervention: NIRS neurofeedback

Control group

Healthy children, 12 sessions of NIRS feedback, for two sessions per week.

Intervention: NIRS neurofeedback

Outcomes

Primary Outcomes

Change in SNAP-IV

Time Frame: Baseline, week 3, week 6, week 8

Change in SNAP-IV(Swanson, Nolan, and Pelham-IV rating scales) score between groups over time

Secondary Outcomes

  • Change in TRS(Baseline, week 3, week 6, week 8)
  • Change in CGI(Baseline, week 3, week 6, week 8)
  • Change in PSQ(Baseline, week 3, week 6, week 8)

Study Sites (1)

Loading locations...

Similar Trials